Trial Profile
Phase Ib Trial of Trastuzumab Emtansine In Combination With Lapatinib Plus Abraxane In Metastatic Her 2 Neu Over-Expressed Breast Cancer Patients
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Lapatinib (Primary) ; Paclitaxel (Primary) ; Trastuzumab emtansine (Primary)
- Indications Advanced breast cancer; HER2 positive breast cancer
- Focus Adverse reactions
- Acronyms STELA
- 12 Apr 2019 Status changed from active, no longer recruiting to completed.
- 25 Jul 2018 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 25 Jul 2018 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2018.